Volume 13, Issue 1

March 2014
(14) Review, (1) Editorial

Editorial

Editorial
  • Güven Aslan
Bull Urooncol 2014; 13: 0-0

Review

The developments in paradigm of prostate cancer in recent years
  • Sertaç Yazıcı
  • Halil Kızılöz
  • Haluk Özen
Bull Urooncol 2014; 13: 1-7
An update on palliative therapy in advanced prostate cancer
  • Kaan Özdedeli
  • Uğur Kuyumcuoğlu
Bull Urooncol 2014; 13: 8-14
Prostate cancer, screening and diagnosis according to EAU and AUA 2013 updates and practical considerations
  • Tünkut Doğanca
  • Can Öbek
Bull Urooncol 2014; 13: 15-20
The role of surgery for high-risk prostate cancer
  • Oktay Üçer
  • Talha Müezzinoğlu
Bull Urooncol 2014; 13: 21-24
Lympadenectomy in prostate cancer
  • Murat Koşan
Bull Urooncol 2014; 13: 25-28
Comparing outcomes of external radiotherapy modalities for prostate cancer
  • Şefik İğdem
Bull Urooncol 2014; 13: 29-32
In which fields intermittent androgen deprivation therapy can be used in 2014?
  • Yasin Ceylan
  • Bu¨lent Gu¨nlu¨soy
Bull Urooncol 2014; 13: 33-36
Open surgery is still gold standard for radical prostatectomy
  • Polat Türker
  • Levent Türkeri
Bull Urooncol 2014; 13: 37-40
Active Surveillance: Treatment Modality that Expect Attention for Localized Prostate Cancer
  • Tayyar Alp Özkan
  • Özdal Dillioğlugil
Bull Urooncol 2014; 13: 41-45
Positron emission tomogrphy in prostate carcinoma
  • Recep Bekiş
Bull Urooncol 2014; 13: 46-49
The role of 5α-reductase inhibitors on prevention and hormonal treatment of prostate cancer
  • Bülent Öztürk
  • Tufan Çiçek
Bull Urooncol 2014; 13: 50-53
The influence of age on localized prostate cancer: Surgical result of patients over 70 years
  • Erdal Benli
  • Ali Ayyıldız
Bull Urooncol 2014; 13: 54-57
Outstanding variations in the treatment of prostate cancer bone metastases
  • İbrahim Cüreklibatır
Bull Urooncol 2014; 13: 58-62
How affected Active Surveillance the quality of life in low-risk localized prostate cancer?
  • İlker Çelen
  • Sinharib Çitgez
  • Talha Müezzinoğlu
Bull Urooncol 2014; 13: 63-66